![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 16, 11064-11071, April 18, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
¶

3
From the
Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences and ||Laboratory of Molecular Neurobiology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan,
Department of Neurology and Program in Neuroscience, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, and ¶Division of Psychosomatic Medicine, Department of Neurology, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishi-ku, Kitakyushu, 807-8555, Japan
Prostaglandin E2 (PGE2) has been shown to produce fever by acting on EP3 receptors within the preoptic area of the brain. However, there is little information about the molecular events downstream of EP3 activation in preoptic neurons. As a first step toward this issue, we examined PGE2-induced gene expression changes at single-cell resolution in preoptic neurons expressing EP3. Brain sections of the preoptic area from PGE2- or saline-injected rats were stained with an anti-EP3 antibody, and the cell bodies of EP3-positive neurons were dissected and subjected to RNA amplification procedures. Microarray analysis of the amplified products demonstrated the possibility that gene expression of
-aminobutyric acid type A (GABAA) receptor subunits is decreased upon PGE2 injection. Indeed, we found that most EP3-positive neurons in the mouse preoptic area are positive for the
2 or
2 GABAA receptor subunit. Moreover, PGE2 decreased the preoptic gene expression of these GABAA subunits via an EP3-dependent and pertussis toxin-sensitive pathway. PGE2 also attenuated the preoptic protein expression of the
2 subunit in wild-type but not in EP3-deficient mice. These results indicate that PGE2-EP3 signaling elicits Gi/o activation in preoptic thermocenter neurons, and we propose the possibility that a rapid decrease in preoptic GABAA expression may be involved in PGE2-induced fever.
Received for publication, February 20, 2008
* This work was supported in part by a grant from the Sankyo Foundation of Life Science and by grants-in-aid for scientific research (B) and on priority areas (Applied Genomics, Mechanisms of Sex Differentiation, and Molecular Brain Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Ministry of Health and Labor of Japan, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.
2 Supported by a fellowship from the Japan Society for the Promotion of Science.
3 To whom correspondence should be addressed: Kyoto University Graduate School of Pharmaceutical Sciences, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Fax: 81-75-753-4557; E-mail: ysugimot{at}pharm.kyoto-u.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |